Navigation Links
Dr. Farshchian to interview Dr. Sandra Doman on "Arthritis Show"
Date:1/11/2013

Miami (PRWEB) January 11, 2013

On January the 11th at 5:30, Dr Sandra Doman will be appearing on "The Arthritis Show" as a guest.
Dr. Sandra L. Doman is a chiropractic physician. She is from Bethesda, Maryland . She earned her doctorate with honors from Palmer College of Chiropractic, Florida Campus and holds a B.S. in Marketing and Economics from Lehigh University in Pennsylvania. Dr. Doman has worked with a variety of athletes including nearly 100 NFL players. She is the President of the Dade County Chiropractic Society. Dr. Doman lectures at health clubs in South Florida on injury prevention and teaches anatomy in 200 hour yoga teacher training programs.

A.J. Farshchian MD will continue to push the envelope, like he did in the past seasons. U.S.A. based physician, Dr. Farshchian, is a medical author, humanitarian, and active republican member. He is best known for coining the term "orthopedic regenerative medicine." Dr. Farshchian is recognized as a leading authority in the new clinical science of regenerative medicine. Viewers can enjoy watching the show live on http://www.arthritisusa.net as it streams live on the internet Mondays, Wednesdays and Fridays at 5:30 P.M. The show also broadcasts on BuenoVision daily at 11:30 A.M.
My Medicine TV programs are independently produced by Mymedicinetv.com. The show provides its viewers an in depth opportunity to find solutions to the health problems from some of the top leaders in health care from across the world. Each exclusive segment is taped in their state of the art south Florida studio."The Arthritis Show" is a global information source dedicated to patients with arthritis and sports injuries.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10304396.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Dr. Farshchian: Plica of the knee is now being treated with regenerative medicine at he center for regenerative medicine.
2. Dr. Farshchian: Advanced Osteoarthritis of the Knee is Now being Treated with Regenerative Medicine at The Center for Regenerative Medicine
3. Dr. Farshchian : The knee joint is now being treated with regenerative medicine at he center for regenerative medicine
4. Dr. Farshchian: Subacromion Bursitis is Now being Treated with Cell Therapy
5. Dr. Farshchian: Chronic Exertional Compartment Syndrome Now Treated at the Center for Regenerative Medicine
6. Dr. Farshchian: The Center for regenerative medicine introduces Genorthix system
7. Dr. Farshchian: Tibialis Posterior Dysfunction is Now Being Treated at The Center for Regenerative Medicine in Miami
8. Dr. Farshchian: Rotator Cuff Injuries are being Treated Now Using Cell Therapy at the Center for Regenerative Medicine
9. Dr. Farshchian: Trochanter Bursitis is Now Treated at the Center for Regenerative Medicine
10. Dr. Farshchian: New treatment on Muscle Atrophy, now available at the Center for Regenerative Medicine
11. Dr. Farshchian: Muscular Contusions are Now Being Treated Successfully at The Center for Regenerative Medicine in Miami
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/3/2015)... ... , ... “Love in Tokyo” an independent romantic comedy film by Michael Solton ... and will be released on DVD early next year, by Maverick Entertainment. The film ... and singer/songwriter, and Jason London, lead from “Dazed and Confused.” , “Love in ...
(Date:9/3/2015)... ... 03, 2015 , ... The new In-Office whitening kit from ... The Clinicians Report is a leading information source to the dental industry. Product ... Whiter Image's In-Office whitening kits were favorably validated for use in the dental ...
(Date:9/3/2015)... ... September 03, 2015 , ... About 220,800 new cases of prostate cancer are reported each ... be diagnosed with prostate cancer during their lifetime. While only one man in 10,000 will ... men by age 65, according to the American Cancer Society. , ...
(Date:9/3/2015)... MA (PRWEB) , ... September 03, 2015 , ... ... today announced that Bob Anders and Kelley Chapman will be joining the company’s ... , Anders has over 30 years’ experience in healthcare product and ...
(Date:9/3/2015)... ... ... Fashion designer Kim (29 years old, Honolulu, HI) designed her own successful ... ABC series “Extreme Weight Loss” Season 5 . Standing just 5’1” and weighing ... the motivation to transform when she designed a drop-dead-gorgeous dress and vowed she would ...
Breaking Medicine News(10 mins):Health News:The Romantic Comedy Film "Love in Tokyo" Has Been Released on ITunes, Google Play, and Amazon 2Health News:Whiter Image Products Get Positive Rating From The Clinicians Report 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 3Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 2Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 3Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 2Health News:New “Extreme Weight Loss” Video Blog from the CU Anschutz Health and Wellness Center: Kim Begins with the End in Mind and Designs a Fashionable Future 3
... team looking for a cure for Duchenne Muscular Dystrophy, an ... findings// recently. ,The Stem cell Studies done by ... those who suffer from the disease. ,Duchenne muscular ... that results in muscle wasting which usually begins in ...
... of a communiqué from Britain about a novel type of ... Britain’s research farm, New Zealand authorities// have requested exact details ... has detected the disease, which is technically called ‘scrapie’ that ... disease. ,Barry O'Neill, the man at the helm ...
... directions for mandatory HIV/ AIDS testing before taking up ... asked the Maharashtra government to consider framing a policy ... PIL filed by an NGO, Maharashtra Law Graduate Association., ... that the National AIDS Prevention and Control Policy of ...
... adopted a new policy it hopes will inspire Australians to ... of life, AMA President, Dr Mukesh Haikerwal,// said today. ... country, with a robust culture of physical activity and the ... trend is blotting our image as a fit and healthy ...
... the NGO, Madras Round Table 1, in an altruistic ... diseases. The novel// partnership has been named ‘Save A ... one child per day’ they aim to give underprivileged ... SACH aims to assist early diagnosis and availability of ...
... may have COPD (Chronic Obstructive Pulmonary Disease), a serious ... general term used for a number of respiratory conditions, ... be the main cause. Early symptoms of COPD include ... during exercise or exertion. ,The Global Initiative ...
Cached Medicine News:Health News:Advance Australia Active – AM 2
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/275q7t/inhaled_drug ) has announced the ... - November 19-20, 2015)" conference to their offering. ... industry case studies, regulatory updates, latest therapies and technology ... Steven Nichols , OINP Specialist Consultant and Mike ... participating include: - Aptar Pharma ...
(Date:9/2/2015)... Research and Markets ( http://www.researchandmarkets.com/research/hcb7bz/pharmaceutical ) has announced the ... - November 16-18, 2015)" conference to their offering. Regulatory ... including Columbia, Peru , Brazil , ... Uruguay , Paraguay , Venezuela ... Chile This seminar can be viewed ...
(Date:9/2/2015)... 2, 2015  Seeger Weiss LLP is reporting that ... commence October 13, 2015. Since the ... approval program, Zimmer NexGen knee implant surpassed FDA investigation ... companies provide evidence that the product is substantially similar ... gain permissions. In 2001, Zimmer began ...
Breaking Medicine Technology:Pharmaceutical Regulatory Affairs in Latin America Seminar - London, UK - November 16-18, 2015 2Seeger Weiss LLP Reports That Zimmer NexGen Knee MDL Bellwether Trial Date Set For October 13, 2015 2
... to Show That Extended,Thromboprophylaxis Reduces VTE Risk ... 44% , PARIS, July 8, 2007 /PRNewswire-FirstCall/ ... (EXtended CLinical,prophylaxis in Acutely Ill Medical patients) ... in acutely ill medical patients,with reduced mobility ...
... Positive Phase IIa Clinical,Trial Results, First clinical ... in AM-Pharma's Pipeline , BUNNIK, The Netherlands, ... novel therapeutics to treat,infectious and inflammatory diseases, ... Phase IIa Alkaline Phosphatase (AP) trial,for patients ...
Cached Medicine Technology:New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 2New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 3New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 4New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 5New Study Shows That Extending Prophylaxis With Clexane / Lovenox,(enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10,Days for Reducing the Risk of Venous Thromboembolism (VTE) in,Acutely ill Medical Patients With Reduced Mobility 6AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 2AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 3AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 4AM-Pharma Announces Positive Results of Phase IIa Clinical Trial,with Alkaline Phosphatase For Ulcerative Colitis 5
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: